Last updated: 2026-09-21 02:43:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Zhengye Biotechnology Holding Limited (ZYBT) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $1.38, with a market capitalization of $64.93M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.62 to $9.56. This page covers its latest market performance, valuation, price trends and company information.
$64.93M | |
$1.35 | |
$14.30 | |
$0.62 | |
$1.37 | |
18.69K | |
5.20M | |
-- | |
$9.56 | |
$0.62 | |
-- | |
-- |
Zhengye Biotechnology Holding Limited (ZYBT) last closed at $1.37 as of 2026-09-18 23:57:00, unchanged from the previous close of $1.37.
During the latest regular trading session, ZYBT traded between $0.62 and $14.30, with a volume of 18.69K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, Zhengye Biotechnology Holding Limited (ZYBT) moved from $1.59 to $1.38, representing a decline of 13.27% ($0.21).
The stock traded between $1.32 and $1.63 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 33.82 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 8.5%
ZYBT is currently trading at $1.38, placing it 8.5% of the way from its 52-week low of $0.62 to its 52-week high of $9.56. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Zhengye Biotechnology Holding Ltd is engaged in research, development, manufacturing, and sales of veterinary vaccines, with an emphasis on vaccines for livestock. It has a diverse range of vaccines, including vaccines for swine, cattle, goats, waterfowl, sheep, poultry, and pets, available in various provincial regions across China and are exported overseas to Vietnam, Pakistan, and Egypt. The company generates maximum revenue from the sale of swine vaccines, followed by poultry and other vaccines.
| Employees | 269 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Zhengye Biotechnology Holding Limited (ZYBT) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.